Andere Sprachen Kyowa Corporation

Aktien

Verzögert Japan Exchange Andere Börsenplätze 02:52:35 29.05.2024			% 5 Tage	% 1. Jan.
900 ^JPY	0,00 %		+2,51 %	+11,52 %

07.05.	Gewinn von Kyowa Kirin steigt in Q1 um 15%	MT
02.05.	BridgeBio Pharma-Aktien geben nach Q1-Finanzergebnissen nach	MT

Kyowa Kirin's Profit Up 15% in Q1	07.05.
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06.05.
BridgeBio Pharma Shares Decline After Q1 Financial Results	02.05.
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03.04.
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25.03.
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25.03.
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20.03.
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	18.03.
US approves first gene therapy for children with rare genetic disease	18.03.
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	05.03.
China Deflation, Bank of Japan Roil Asian Stock Markets	08.02.
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	08.02.
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	08.02.
BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan	07.02.
Kyowa Kirin's Profit Up 52% in Fiscal 2023	07.02.
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January	26.01.
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics	26.01.
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin	24.01.
Aosaikang Pharmaceutical Registers Breast Cancer Drug	23.01.
Kyowa Kirin’s Attributable Profit up 8.8% in Nine Months Ended Sept. 30 on Gain on Sales of Share and Valuation	02.11.

Keine Ergebnisse zu dieser Suche